Bakir B, Chiarella AM, Pitarresi JR, Rustgi AK. EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol. 2020;30(10):764–76.

Article  PubMed  PubMed Central  Google Scholar 

Chang CM, Chang PY, Tu MG, Lu CC, Kuo SC, Amagaya S, et al. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2. Oncol Rep. 2012;28:1799–807.

Article  CAS  PubMed  Google Scholar 

Chang WS, Tsai CW, Yang JS, et al. Resveratrol inhibited the metastatic behaviors of cisplatin-resistant human oral cancer cells via phosphorylation of ERK/p-38 and suppression of MMP-2/9. J Food Biochem. 2021;45(6):e13666.

Article  CAS  PubMed  Google Scholar 

Chatterjee A, Rodger EJ, Eccles MR. Epigenetic drivers of tumourigenesis and cancer metastasis. Semin Cancer Biol. 2018;51:149–59.

Article  CAS  PubMed  Google Scholar 

Chen L, Zhuo D, Chen J, Yuan H. Screening feature genes of lung carcinoma with DNA microarray analysis. Int J Clin Exp Med. 2015;8:12161–71.

CAS  PubMed  PubMed Central  Google Scholar 

Chen WS, Bindra RS, Mo A, et al. CDKN2A copy number loss is an independent prognostic factor in HPV-negative head and neck squamous cell carcinoma. Front Oncol. 2018;8:95.

Article  PubMed  PubMed Central  Google Scholar 

Chen HT, Liu H, Mao MJ, et al. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy. Mol Cancer. 2019;18(1):101.

Article  PubMed  PubMed Central  Google Scholar 

Chuang JY, Huang YL, Yen WL, Chiang IP, Tsai MH, Tang CH. Syk/JNK/AP-1 signaling pathway mediates interleukin-6-promoted cell migration in oral squamous cell carcinoma. Int J Mol Sci. 2014;15:545–59.

Article  PubMed  PubMed Central  Google Scholar 

Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA. 2010;107:21931–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cyr-Depauw C, Northey JJ, Tabariès S, et al. Chordin-Like 1 suppresses bone morphogenetic protein 4-induced breast cancer cell migration and invasion. Mol Cell Biol. 2016;36(10):1509–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng H, Hang Q, Shen D, Zhang Y, Chen M. Low expression of MED29 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation. Cancer Cell Int. 2021;21:259.

Article  PubMed  PubMed Central  Google Scholar 

Dymerska D, Marusiak AA. Drivers of cancer metastasis–Arise early and remain present. Biochim Biophys Acta Rev Cancer. 2024;1879(2):189060.

Article  CAS  PubMed  Google Scholar 

Gu J, Zhang J, Xia R, et al. The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance. Drug Resist Updat. 2024;73:101027.

Article  CAS  PubMed  Google Scholar 

Huang J, Wei X, Ma W, Yuan Z. The miR-532-3p/Chrdl1 axis regulates the proliferation and migration of amniotic fluid-derived mesenchymal stromal cells. Biochem Biophys Res Commun. 2020;527(1):187–93.

Article  CAS  PubMed  Google Scholar 

Jeronimo C, Robert F. Kin28 regulates the transient association of Mediator with core promoters. Nat Struct Mol Biol. 2014;21:449–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jha A, Alam M, Kashyap T, et al. Crosstalk between PD-L1 and Jak2-Stat3/MAPK-AP1 signaling promotes oral cancer progression, invasion and therapy resistance. Int Immunopharmacol. 2023;124(Pt A):110894.

Article  CAS  PubMed  Google Scholar 

Jiang YZ, Liu YR, Xu XE, Jin X, Hu X, Yu KD, et al. Transcriptome analysis of triple-negative breast cancer reveals an integrated mRNA-lncRNA signature with predictive and prognostic value. Cancer Res. 2016;76:2105–14.

Article  CAS  PubMed  Google Scholar 

Jolly MK, Somarelli JA, Sheth M, et al. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas. Pharmacol Ther. 2019;194:161–84.

Article  CAS  PubMed  Google Scholar 

Kashyap T, Pramanik KK, Nath N, et al. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer. Oral Oncol. 2018;86:234–43.

Article  CAS  PubMed  Google Scholar 

Kim SA, Lee KH, Lee DH, et al. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma. Int J Oncol. 2019;55(2):513–26.

CAS  PubMed  Google Scholar 

Knoll ER, Zhu ZI, Sarkar D, Landsman D, Morse RH. Role of the pre-initiation complex in Mediator recruitment and dynamics. Elife. 2018;7:e39633.

Article  PubMed  PubMed Central  Google Scholar 

Kuuselo R, Savinainen K, Azorsa DO, et al. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification. Cancer Res. 2007a;67(5):1943–9.

Article  CAS  PubMed  Google Scholar 

Kuuselo R, Savinainen K, Azorsa DO, Basu GD, Karhu R, Tuzmen S, et al. Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplifcation. Cancer Res. 2007b;67:1943–9.

Article  CAS  PubMed  Google Scholar 

Kuuselo R, Savinainen K, Sandström S, Autio R, Kallioniemi A. MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer. Int J Cancer. 2011;129(11):2553–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li JW, Zhou J, Shi ZT, Li N, Zhou SC, Chang C. Sonographic features of triple-negative breast carcinomas are correlated with mRNA-lncRNA signatures and risk of tumor recurrence. Front Oncol. 2020;10(587422):587422.

PubMed  Google Scholar 

Lindemann A, Patel AA, Silver NL, et al. COTI-2, a novel thiosemicarbazone derivative, exhibits antitumor activity in HNSCC through p53-dependent and -independent mechanisms. Clin Cancer Res. 2019;25(18):5650–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mock K, Preca BT, Brummer T, Brabletz S, Stemmler MP, Brabletz T. The EMT-Activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors. Oncotarget. 2015a;6:14399–412.

Article  PubMed  PubMed Central  Google Scholar 

Mock K, Preca BT, Brummer T, Brabletz S, Stemmler MP, Brabletz T. The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors. Oncotarget. 2015b;6(16):14399–412.

Article  PubMed  PubMed Central  Google Scholar 

Mulloy B, Rider CC. The bone morphogenetic proteins and their antagonists. Vitam Horm. 2015;99:63–90.

Article  CAS  PubMed  Google Scholar 

Pei YF, Zhang YJ, Lei Y, Wu WD, Ma TH, Liu XQ. Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer. Oncotarget. 2017a;8(29):48526.

Article  PubMed  PubMed Central  Google Scholar 

Pei YF, Zhang YJ, Lei Y, Wu WD, Ma TH, Liu XQ. Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer. Oncotarget. 2017b;8(14):23155–66.

Article